457 results on '"Nadeu, Ferran"'
Search Results
2. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma
3. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target
4. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation
5. Molecular map of chronic lymphocytic leukemia and its impact on outcome
6. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features
7. MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms
8. Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes
9. From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia
10. Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma
11. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
12. Unraveling the genetics of transformed splenic marginal zone lymphoma
13. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
14. PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2
15. Correction: ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution
16. The genomic landscape of transformed splenic diffuse red pulp small B‐cell lymphoma.
17. Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.
18. Signatures of TOP1 transcription-associated mutagenesis in cancer and germline
19. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features
20. ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution
21. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia
22. Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma
23. RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia
24. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
25. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era
26. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
27. mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies
28. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
29. Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosis
30. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation
31. Evolutionary dynamics of 1,976 lymphoid malignancies predict clinical outcome
32. A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma
33. All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
34. Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
35. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration
36. Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline
37. The U1 spliceosomal RNA is recurrently mutated in multiple cancers
38. BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
39. P600: DNA METHYLATION ANALYSIS OF B-CELL PROLYMPHOCYTIC LEUKEMIA REVEALS TWO EPIGENETIC SUBTYPES WITH DISTINCT BIOLOGICAL AND CLINICAL FEATURES
40. P608: THE EXPRESSION OF CYTOR LNCRNA HAS POOR PROGNOSTIC VALUE IN CLL PATIENTS AND IS ASSOCIATED WITH MICROENVIRONMENTAL STIMULI.
41. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
42. Timing the initiation of multiple myeloma
43. Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience
44. A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
45. Robust identification of conventional and leukemic nonnodal mantle cell lymphomas using epigenetic biomarkers.
46. A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses
47. Supplementary tables from Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
48. Supplementary Data from A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma
49. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status:a study by ERIC in HARMONY
50. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.